selected scholarly activity
-
conferences
- Effectiveness and Safety of Infliximab in Ankylosing Spondylitis: A Multi-Centre, Prospective, Observational Study from the Biologic Treatment Registry Across Canada (BioTRAC). Journal of Rheumatology. 850-850. 2019
- Long-Term Effectiveness and Safety of Infliximab in Rheumatoid Arthritis Patients: Real-World Data from the Biologic Treatment Registry Across Canada (BioTRAC). Journal of Rheumatology. 786-786. 2019
- AB0704 EFFECTIVENESS AND SAFETY OF INFLIXIMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS PATIENTS FROM A PROSPECTIVE OBSERVATIONAL REGISTRY. Annals of the Rheumatic Diseases. 1814-1814. 2019
- Improvement in Work Productivity and Fatigue of Certolizumab Pegol in Rheumatoid Arthritis Patients in a Canadian Practice Setting: Two Year Results from the Non-Interventional F-alphasT CAN Study. Journal of Rheumatology. 1050-1050. 2018
- Incidence of Extra-Articular Manifestations in PsA and AS Patients Treated with Golimumab in Canadian Real-World. Journal of Rheumatology. 1020-1020. 2018
- The Effectiveness and Safety of Certolizumab Pegol in Rheumatoid Arthritis Patients in a Canadian Practice Setting: Two Year Results from the Non-Interventional F-alphasT CAN Study. Journal of Rheumatology. 1050-1050. 2018
- Incidence of Extra-Articular Manifestations in Psa and As Patients Treated with Golimumab in Canadian Real-World. Arthritis & Rheumatology. 2017
- Impact of HLA-B27 on Patient Profile and Treatment Response in AS Patients Treated with Anti-TNF in Canadian Real-world Setting. Journal of Rheumatology. 910-910. 2017
- Impact of HLA-B27 on Patient Profile and Treatment Response in As Patients Treated with Anti-TNF in Canadian Real-World. Arthritis & Rheumatology. 2016
- Does Treatment Improve HAQ or Do Patients Adjust How They Do Things? An Exploration of the HAQ-DI vs the HAQ-ADI over Time. Journal of Rheumatology. 1347-1348. 2015
- Predictors of Response in Patients with Psoriatic Arthritis Treated with Anti-TNF in a Real-World Setting. Journal of Rheumatology. 1347-1347. 2015
- Prevalence of Smoking and Impact on Disease Parameters Among Ankylosing Spondylitis, Rheumatoid Arthritis and Psoriatic Arthritis Patients Treated with Infliximab or Golimumab in Canada. Journal of Rheumatology. 1330-1331. 2015
- The Safety and Efficacy of Certolizumab Pegol in Rheumatoid Arthritis used in Routine Canadian Clinical Practice: Interim Analysis of the FasT CAN Study. Journal of Rheumatology. 1333-1333. 2015
- AB1163 Prevalence of Smoking and Impact on Disease Parameters Among Ankylosing Spondylitis, Rheumatoid Arthritis and Psoriatic Arthritis Patients Treated with Infliximab or Golimumab. Annals of the Rheumatic Diseases. 1291.3-1292. 2015
- SAT0338 Does Treatment Improve HAQ or Do Patients Adjust How They Do Things? An Exploration of the HAQ-DI Vs the HAQ-ADI Over Time. Annals of the Rheumatic Diseases. 781.2-781. 2015
- SAT0557 Predictors of Response in Patients with Psoriatic Arthritis Treated with Anti-TNF in a Real-World Setting. Annals of the Rheumatic Diseases. 861.3-862. 2015
- Impact of Corticosteroid Use on Remission Sustainability and Infection Rates Among Rheumatoid Arthritis Patients in Remission While on Infliximab: Treatment Implications Based on a Real-World Canadian Population.. Arthritis & Rheumatology. S616-S616. 2014
- Predictors of ACR/EULAR Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: An Analysis from the Prospective, Observational, Biological Treatment Registry Across Canada. Arthritis & Rheumatology. S1090-S1091. 2014
- Are there Gender Specific Differences in Patient Reported Outcomes at Initiation of Golimumab Treatment in Rheumatoid Arthritis?. Journal of Rheumatology. 1450-1451. 2014
- Correlation of Individual HAQ Questions with Outcome Measures in Rheumatoid Arthritis: Implications for Instrument Reduction. Journal of Rheumatology. 1445-1446. 2014
- Corticosteroid Use in Rheumatoid Arthritis Patients on Infliximab: Treatment Implications and Impact on Durability of Response Based on a Real-World Canadian Population. Journal of Rheumatology. 1444-1445. 2014
- Does Specific Joint Involvement in Rheumatoid Arthritis Patients Predict Patient Reported Outcomes? Implications for Clinical Practice. Journal of Rheumatology. 1449-1450. 2014
- Multicenter Validation of the Lupus Activity Scoring Tool (LAST) as Compared to the SELENA SLEDAI (SS) Modification. Journal of Rheumatology. 1468-1468. 2014
- Predictors of ACR/EULAR Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: An Analysis from the Prospective, Observational Registry, BioTRAC. Journal of Rheumatology. 1443-1444. 2014
- Use of an Online Questionnaire to Disseminate CRA Guidelines for RA Management. Journal of Rheumatology. 1487-1488. 2014
- Variability in Patient Characteristics and Outcomes in Rheumatoid Arthritis upon Infliximab Treatment Based on the Size of Biologic Treatment Registry Site. Journal of Rheumatology. 1445-1445. 2014
- Variability in the Classification of Remission Among Disease Activity Indices and their Correlation: An Analysis from a Prospective, Observational Registry. Journal of Rheumatology. 1481-1481. 2014
- AB0228 Variability in Patient Characteristics and Outcomes in Rheumatoid Arthritis upon Infliximab Treatment Based on the Size of the Biologic Treatment Registry Site. Annals of the Rheumatic Diseases. 879.1-879. 2014
- AB1044 Are There Gender Specific Differences in Patient Reported Outcomes at Initiation of Golimumab Treatment in Rheumatoid Arthritis?. Annals of the Rheumatic Diseases. 1145.2-1145. 2014
- SAT0035 Impact of Corticosteroid Use on Remission Sustainability and Infection Rates among Rheumatoid Arthritis Patients in Remission While on Infliximab: Treatment Implications Based on A Real-World Population. Annals of the Rheumatic Diseases. 601.2-601. 2014
- SAT0083 Does Specific Joint Involvement in Rheumatoid Arthritis Patients PREDICT Patient Reported Outcomes? Implications for Clinical Practice. Annals of the Rheumatic Diseases. 620.2-620. 2014
- THU0241 Predictors of Acr/Eular Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: an Analysis from the Prospective, Observational Registry, Biotrac. Annals of the Rheumatic Diseases. 265.2-265. 2014
- Correlation Of Individual Health Assessment Questionnaire (HAQ) Questions With Outcome Measures In Rheumatoid Arthritis: Implications For Instrument Reduction.. Arthritis and Rheumatism. S973-S973. 2013
- Corticosteroid Use In Rheumatoid Arthritis Patients On Infliximab: Treatment Implications Based On A REAL-WORLD Canadian Population. Arthritis and Rheumatism. S620-S621. 2013
- Does Specific Joint Involvement In Rheumatoid Arthritis Patients Predict Patient Reported Outcomes? Implications For Clinical Practice. Arthritis and Rheumatism. S77-S77. 2013
- Multicenter Validation Of The Lupus Activity Scoring Tool (LAST) As Compared To The Selena Sledai (SS) Modification. Arthritis and Rheumatism. S1072-S1072. 2013
- Variability In Patient Characteristics and Outcomes In Rheumatoid Arthritis Upon Infliximab Treatment Based On The Size Of Biologic Treatment Registry Site. Arthritis and Rheumatism. S1019-S1020. 2013
- Variability in the Classification of Remission Among Disease Activity Indices and Their Correlation: An Analysis From a Prospective, Observational Registry. Arthritis and Rheumatism. S957-S958. 2013
- CORRELATION OF INDIVIDUAL HAQ QUESTIONS WITH OUTCOME MEASURES IN RHEUMATOID ARTHRITIS: IMPLICATIONS FOR INSTRUMENT REDUCTION. Annals of the Rheumatic Diseases. 206-207. 2013
- CORTICOSTEROID USE IN RHEUMATOID ARTHRITIS PATIENTS ON INFLIXIMAB: TREATMENT IMPLICATIONS BASED ON A REAL-WORLD CANADIAN POPULATION. Annals of the Rheumatic Diseases. 224-224. 2013
- Certolizumab Pegol Improves Productivity at Paid Work and within the Household in Adult Rheumatoid Arthritis Patients in Daily Practice in Canada: Interim Analysis of the Observational Noninterventional FasT CAN Study. Journal of Rheumatology. 985-986. 2013
- Corticosteroid use in Rheumatoid Arthritis Patients Taking Infliximab: Treatment Implications Based on a Real-world Canadian Population. Journal of Rheumatology. 961-962. 2013
- First Report of Golimumab Real-World Effectiveness in Low/Moderate and High Disease Activity in Patients with Rheumatoid Arthritis. Journal of Rheumatology. 1021-1021. 2013
- SAFETY, EFFECTIVENESS, WORK AND HOUSEHOLD PRODUCTIVITY OF ANTI-TNF ALPHA THERAPY WITH CERTOLIZUMAB PEGOL OBSERVED IN ADULT RHEUMATOID ARTHRITIS PATIENTS IN DAILY PRACTICE IN CANADA: FIRST INTERIM ANALYSIS OF THE NON-INTERVENTIONAL FAST CAN STUDY. Annals of the Rheumatic Diseases. 874-875. 2013
- Safety and Effectiveness of TNF-Alpha Inhibitor Therapy with Certolizumab Pegol Observed in Daily Practice in Adult Rheumatoid Arthritis Patients in Canada - First Interim Analysis of the Noninterventional FasT CAN Study. Journal of Rheumatology. 961-961. 2013
- VARIABILITY IN THE CLASSIFICATION OF REMISSION AMONG DISEASE ACTIVITY INDICES AND THEIR CORRELATION: AN ANALYSIS FROM A PROSPECTIVE, OBSERVATIONAL REGISTRY. Annals of the Rheumatic Diseases. 591-592. 2013
- Use of Oral Contraceptive Pills in Patients with SLE - A Survey of Rheumtologists in Canada. Journal of Rheumatology. 1325-1325. 2010
- Oral contraceptives and systemic lupus erythematosus, current practice in Hamilton. Journal of Rheumatology. 1192-1192. 2008
- Characteristics of women referred to a mature women's health program for gynecologic assessment and treatment. Menopause. 599-599. 2003
-
journal articles
- Impact of the COVID-19 Pandemic on People Living with Rheumatoid Arthritis: Experiences and Preferences in Accessing Healthcare Across Five Countries. Rheumatology and Therapy. 11:257-268. 2024
- Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative.. Clinical and Experimental Rheumatology. 41:2249-2256. 2023
- Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study. Arthritis Care and Research. 75:240-251. 2023
- Physician- and Patient-reported Effectiveness Are Similar for Tofacitinib and TNFi in Rheumatoid Arthritis: Data From a Rheumatoid Arthritis Registry. Journal of Rheumatology. 49:447-453. 2022
- Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort. PLoS ONE. 17:e0274264-e0274264. 2022
- Heterogeneity in Patient Characteristics and Differences in Treatment Across 4 Canadian Rheumatoid Arthritis Cohorts. Journal of Rheumatology. 49:16-25. 2022
- Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study. Therapeutic Advances in Musculoskeletal Disease. 11:1759720X1983115-1759720X1983115. 2019
- Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis. BMJ Open. 6:e009661-e009661. 2016
- Use of corticosteroids in patients with rheumatoid arthritis treated with infliximab: treatment implications based on a real-world Canadian population. RMD Open. 1:e000078-e000078. 2015
- Correction: Oral Contraceptives and Systemic Lupus Erythematosus, Current Practice in Hamilton. Journal of Rheumatology. 37:1788.2-1788. 2010